Thermo Fisher Scientific Inc/ US8835561023 /
| 2024-05-31 10:10:00 PM | Chg. +5.22 | Volume | Bid10:15:51 AM | Ask10:15:51 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 567.98USD | +0.93% | 2.11 mill. Turnover: 659.31 mill. |
535.50Bid Size: 100 | 568.60Ask Size: 100 | 216.81 bill.USD | 0.25% | 36.60 |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 4,165 | 4,749 | 5,912 | 8,333 | 9,280 | ||||||
| Intangible Assets | 14,978 | 14,014 | 12,685 | 20,113 | 17,442 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 45,607 | 46,488 | 47,095 | 75,010 | 71,925 | ||||||
| Inventories | 3,005 | 3,370 | 4,029 | 5,051 | 5,634 | ||||||
| Accounts Receivable | 4,136 | 4,349 | 5,741 | 7,977 | 8,115 | ||||||
| Cash and Cash Equivalents | 2,103 | 2,399 | 10,325 | 4,477 | 8,524 | ||||||
| Current Assets | 10,625 | 11,893 | 21,957 | 20,113 | 25,229 | ||||||
| Total Assets | 56,232 | 58,381 | 69,052 | 95,123 | 97,154 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1,615 | 1,920 | 2,175 | 2,867 | 3,381 | ||||||
| Long-term debt | 17,719 | 17,076 | 19,107 | 32,333 | 28,909 | ||||||
| Liabilities to Banks | 1,271 | 676 | 2,628 | 2,537 | - | ||||||
| Provisions | 2,265 | 2,192 | 1,794 | 3,837 | - | ||||||
| Liabilities | 28,646 | 28,706 | 34,545 | 54,268 | 53,122 | ||||||
| Share Capital | 432 | 434 | 437 | 439 | 441 | ||||||
| Total Equity | 27,586 | 29,675 | 34,507 | 40,855 | 44,032 | ||||||
| Minority Interests | - | - | - | 62 | 54 | ||||||
| Total liabilities equity | 56,232 | 58,381 | 69,052 | 95,123 | 97,154 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 24,358 | 25,542 | 32,218 | 39,211 | 44,915 | ||||||
| Depreciation (total) | - | 2,274 | 2,325 | 2,592 | 3,381 | ||||||
| Operating Result | 3,783 | 4,594 | 7,794 | 10,028 | 8,393 | ||||||
| Interest Income | -530 | -452 | -488 | -493 | -454 | ||||||
| Income Before Taxes | 3,262 | 4,070 | 7,225 | 8,841 | 7,835 | ||||||
| Income Taxes | -324 | -374 | -850 | -1,109 | -703 | ||||||
| Minority Interests Profit | - | - | - | 3 | 10 | ||||||
| Net Income | 2,938 | 3,696 | 6,375 | 7,725 | 6,950 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 4,543 | 4,973 | 8,289 | 9,312 | 9,154 | ||||||
| Cash Flow from Investing Activities | -1,253 | -1,487 | -1,510 | -21,932 | -2,159 | ||||||
| Cash Flow from Financing | -2,237 | -3,118 | 959 | 6,581 | -2,810 | ||||||
| Decrease / Increase in Cash | 756 | 305 | 7,914 | -5,845 | 4,046 | ||||||
| Employees | 70,000 | 75,000 | 80,000 | 130,000 | - | ||||||
